EHC vs UHS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
EHC Captures Institutional Edge (3โ1 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Encompass Health Corporation Common Stock (EHC) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while UHS counters with relative strength in Valuation. Fundamentally, EHC trades at 19.4x Forward P/E with 18.4% operating margin (+8.9% YoY revenue) versus UHS at 7.8x Forward P/E and 10.8% operating margin (+5.3% YoY). In options structure, EHC sits in CONSOLIDATION (8th %ile IV; Dealer Gamma Walls on Pro) against UHS sits in CONSOLIDATION (22nd %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | EHC Revenue | UHS Revenue | EHC Op. Margin | UHS Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $4.28B | $10.8B | 13.0% | 10.9% | EHC |
| FY2019 | $4.61B | $11.4B | 13.3% | 10.7% | EHC |
| FY2020 | $3.57B | $11.6B | 15.8% | 11.8% | EHC |
| FY2021 | $4.01B | $12.6B | 13.9% | 10.8% | EHC |
| FY2022 | $4.35B | $13.4B | 12.4% | 7.5% | EHC |
| FY2023 | $4.80B | $14.3B | 7.3% | 8.2% | UHS |
| FY2024 | $5.37B | $15.8B | 8.5% | 10.6% | UHS |
| FY2025 | $5.94B | $17.4B | 9.5% | 11.5% | UHS |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | EHC | UHS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $13.0B | $10.1B | Larger Scale | EHC |
| Trailing P/E Ratio Valuation | 21.2x | 7.3x | Lower Multiple | UHS |
| Forward P/E Ratio Valuation | 19.4x | 7.8x | Lower Multiple | UHS |
| Revenue Growth (YoY) Growth | +8.9% | +5.3% | Higher Growth | EHC |
| Operating Margin (TTM) Profitability | 18.4% | 10.8% | Higher Margin | EHC |
| Net Profit Margin Profitability | 10.2% | 8.0% | Higher Margin | EHC |
| Return on Equity (ROE) Capital Efficiency | 25.1% | 19.7% | Higher ROE | EHC |
| 52-Week Range Position Momentum | 80% ($93โ$144) | 37% ($140โ$246) | Stronger Trend | EHC |
| Beta / 30D Volatility Risk Regime | -0.10ฮฒ ยท 40% Vol | 0.09ฮฒ ยท 54% Vol | Lower Realized Risk | EHC |
| Unified Institutional Score Composite Signal | 52.0 / 100 (HOLD) | 45.6 / 100 (HOLD) | Higher Composite | EHC |